Afalaza is developed - a product for improving common urinary tract problems in men
The start of commercial production of Rengalin -
an innovative product for treating dry and productive cough
The start of commercial production of Divaza - a product for treating chronic cerebrovascular disease
The in-house R&D laboratory is opened
Materia Medica obtained certificates from State administration of Ukraine on Medicinal Products (SAUMP) and Slovakia State Institute for Drug control (SIDC)
Production expansion and launch of vitamin-mineral supplements
Multifort and Multifort kids (dietary supplement)
of Tenoten kids
Tenoten kids is the only sedative medicine developed especially for children in accordance with children constitution features.
Changes in registration status
of Anaferon and Anaferon kids
The medical community officially recognized that Anaferon and Anaferon kids are medicinal products and no more homeopathic ones.
The manufactory in Tchelyabinsk opened new workshops and expanded production
New hi-tech equipement from Italy and Germany enables to unify full production cycle of solid dosage forms.
Discovery of phenomenons of overdilute solutions
The company started intensive multi-centre clinical trials and developments of the new class of medicines based on ultra-low doses of antibodies to endogenous regulators.
At the end of nineties the company’s portfolio included 10 homeopathic medicines of different pharmacological groups
Owing to combination of high safety profile and efficacy, homeopathic medicines quickly gained doctors’ and patients’ confidence.